V8 Peptides — Engineered Performance
Research Library
Selank Research Peptide: What the Evidence Shows
SelankPreclinical

Selank Research Peptide: What the Evidence Shows

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What is the Selank research peptide, in one page? Selank is a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, built from the tuftsin tetrapeptide plus a Pro-Gly-Pro tail. Published preclinical work about it falls into five evidence tiers: chemistry and lineage, in vitro enzyme assays, receptor-binding and cell studies, rodent gene-expression profiling, and rodent behavior and immune readouts. The tiers differ widely in strength, and the mechanism remains at the pathway level. V8 Peptides supplies Selank as a 10 mg lyophilized vial with a stated purity of ≥98% by HPLC, for laboratory research use only.

A "complete guide" to a research peptide is only useful if it separates what has been measured from what has been suggested. This article is organized as an evidence map: each section states a tier, what kind of experiment sits in it, and how a manuscript or lab notebook should word a finding from that tier. It complements the longer Selank research guide and the shorter what is Selank explainer, and it is written for laboratory research use only.

Tier 1: chemistry and lineage

Selank is seven residues long. The first four, Thr-Lys-Pro-Arg, are the tuftsin sequence, a natural immunomodulating tetrapeptide; the added Pro-Gly-Pro was introduced to resist breakdown. A review of tuftsin and its analogs collected the literature on the parent peptide and its derivatives, grouping them by anti-tumor, anti-inflammatory, antimicrobial and anti-viral activity (reference 1). On the receptor side, tuftsin has been reported to bind neuropilin-1 on microglia and signal through the TGF-beta pathway, and an inhibitor that blocks that binding reversed an anti-inflammatory shift induced by tuftsin (reference 2). That is a statement about tuftsin, not Selank; the abstracts cited here do not show that the heptapeptide uses the same route, so it should not be assumed.

PropertyValueSource
SequenceThr-Lys-Pro-Arg-Pro-Gly-ProProduct page
Molecular formulaC33H57N11O9Product page
Vial size10 mg, lyophilized powder, sealed clear glass vialProduct page
Purity specification≥98% by HPLCProduct page; lot data on the COA page where published
Storage2–8 °C; −20 °C long-term; protect from heat, moisture and lightProduct page

Tier 2: in vitro enzyme assays

The most quantitative Selank data are enzyme-inhibition measurements. A study of plasma enkephalin hydrolysis reported dose-dependent inhibition by Selank with an IC50 of 15 µM (reference 3). A human-serum study reported IC50 values of 20 µM for Selank and 10 µM for Semax, with pentapeptide fragments also active (reference 4). These numbers are useful for a bench scientist because they are concentrations in an assay, not amounts given to animals. They also have limits: enkephalin-degrading enzymes are a family, the substrates and sera differ between studies, and an IC50 in the micromolar range does not by itself say whether similar concentrations are reached in tissue.

Wording: "inhibited enkephalin hydrolysis in vitro with a reported IC50 of 15–20 µM." Not: "raises enkephalin levels."

Tier 3: receptor binding and cell studies

A radioligand-binding study described Selank as affecting [3H]GABA binding to brain-cell membranes as a positive allosteric modulator, and found that joint action with some benzodiazepines was not additive (reference 5). In hippocampal slices, 1–8 µM Selank raised the amplitude and discharge rate of spontaneous inhibitory postsynaptic currents in CA1 pyramidal neurons (reference 6). A cell-culture study in IMR-32 neuroblastoma cells reported no change in measured GABAergic gene mRNA with Selank alone (reference 7). Read together, these results fit a modulatory role in GABAergic signaling in membranes and slices and illustrate that a cell line without the relevant circuit may not show the effect.

Tier 4: rodent gene-expression profiling

Expression studies are broad and hypothesis-generating. In rat frontal cortex, a panel of 84 neurotransmission genes showed changes in 45 genes one hour after Selank or GABA at 300 µg/kg and 22 genes at three hours, with correlated changes between the two (reference 8). In rat hippocampus, a microarray study after intranasal administration found 36 genes changed more than two-fold after a single exposure and 20 after a course (reference 9). In mouse spleen, a panel of 84 inflammation genes showed significant changes in 34 genes at 6 and 24 hours after a single intraperitoneal administration of 100 µg/kg, including Bcl6 and some of its target and corepressor genes (reference 10).

These are surveys. A gene-expression change shows that something happened to the transcriptome at a time point; it does not show a functional consequence, and multiple-comparison control matters in panels of this size. The wording should include the tissue, the time and the number of genes.

Tier 5: rodent behavior and immune readouts

Behavioral work is the weakest tier in terms of reproducibility and the one most often overstated. Mouse studies report effects in BALB/c and not C57BL/6 animals, and the behavioral effect appeared with both intranasal and intraperitoneal administration in that comparison (reference 11). A rat study reported that Selank prevented an ethanol-induced rise in hippocampal and frontal-cortex BDNF content (reference 12). A stress paradigm in rats measured cytokine levels in animals exposed to repeated social confrontation, with the authors describing a stress-protective pattern (reference 13). Each is a single paradigm in a single population.

Rodent paradigms such as the open field and elevated plus-maze each measure something slightly different, so a behavioral claim should always name the model and strain.

What is still open

TierExperiment typeStrengthTypical wording
1Chemistry and lineageEstablished"A tuftsin-derived heptapeptide with a Pro-Gly-Pro tail"
2In vitro enzyme assaysQuantitative, assay-specific"Inhibited enkephalin hydrolysis in vitro (IC50 in the micromolar range)"
3Binding, slices, cellsPreparation-specific"Modulated GABA binding in membranes"
4Gene-expression panelsHypothesis-generating"Changed expression of N genes in tissue X at time Y"
5Behavior and immune readoutsStrain- and lab-dependent"Altered a named readout in a named strain"
  • Receptor identity. No single receptor is established for Selank. The enzyme, GABA-binding and immune-gene findings could be separate observations or aspects of one mechanism.
  • Concentration relevance. IC50 values are micromolar; tissue concentrations after administration are not established by the abstracts cited here.
  • Replication. Many primary studies come from a small number of laboratories, with different strains, doses and routes.
  • Strain and context dependence. The same compound appears active in one mouse strain and inactive in another.
  • Fragment contributions. Pentapeptide fragments inhibited enkephalin-degrading enzymes in one study, and in mouse spleen both Selank and two fragments changed Bcl6 expression (references 4 and 10). Whether the tail or the tuftsin portion drives a given readout is therefore an open design question, and a fragment control is informative.

The sister peptide Semax shares the Pro-Gly-Pro tail; it is compared in Selank versus Semax, and a combined-design discussion is in the stack article of this series.

Working with the material

Handling is straightforward. Keep the sealed vial at 2–8 °C, or at −20 °C for long-term holding, away from light and moisture. Warm it to room temperature before opening. Dissolve in the chosen diluent without shaking, and calculate concentration as vial mass divided by diluent volume (C = m ÷ V); the reconstitution calculator does the unit conversions. Divide a frozen stock into single-use portions. General guidance is in how to reconstitute a lyophilized peptide and storing research peptides, and the long-standing stability literature on peptides and proteins covers aggregation, chemical degradation and freezing stress (reference 14).

For documentation, file the lot number and any HPLC figure with each experiment; Selank purity testing and understanding HPLC purity explain what a purity percentage does and does not say. Sourcing context is in where to buy Selank, and the shop lists the full range. All material is for laboratory research use only.

Frequently asked questions

What is Selank?

A synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, made by extending the tuftsin tetrapeptide with a Pro-Gly-Pro tail. It is studied in neuroscience and immunology models.

What is the strongest kind of evidence for Selank?

Quantitative in vitro enzyme assays, which report IC50 values in the micromolar range for inhibition of enkephalin-degrading enzymes. Behavioral findings are less consistent and depend on strain.

Is there a confirmed receptor for Selank?

No. Reports describe enzyme inhibition, positive allosteric modulation of GABA binding in membranes, and gene-expression and immune readouts. The tuftsin parent has been linked to neuropilin-1, but this is not shown for Selank.

What does Selank do to gene expression in rodents?

Published panels report changes in dozens of genes in rat frontal cortex, rat hippocampus and mouse spleen. These surveys document that expression changed but do not establish function.

Why does mouse strain matter?

Cited mouse comparisons found effects in BALB/c mice and not in C57BL/6 mice. Baseline anxiety and exploration differ between the strains.

Do fragments of Selank have activity?

In one human-serum assay, pentapeptide fragments inhibited enkephalin-degrading enzymes while tri-, tetra- and hexapeptide fragments did not. In mouse spleen, Selank and two fragments changed Bcl6 expression.

What are the key specifications of the V8 vial?

10 mg, lyophilized powder, sealed clear glass vial, purity stated as ≥98% by HPLC, formula C33H57N11O9, stored at 2–8 °C with −20 °C for long-term holding.

How is stock concentration calculated?

Concentration in mg/mL equals vial mass in mg divided by diluent volume in mL. The site's calculator applies the formula and converts units.

Where are certificates of analysis listed?

On the COA page, where a certificate has been published for a lot. Record the lot number with the experiment.

Is this guide about use outside the laboratory?

No. It summarizes preclinical literature and bench handling. Selank is supplied for laboratory research use only.

Related reading: Selank and Semax Stack Research: Combination Design, Selank vs Semax: Readout-by-Readout Research Ledger, Selank Storage and Stability: A Sequence-Based View.

References

  1. Siebert A, Gensicka-Kowalewska M, Cholewinski G, Dzierzbicka K. Tuftsin - Properties and Analogs. Curr Med Chem. 2017;24(34):3711-3727. doi:10.2174/0929867324666170725140826
  2. Nissen JC, Selwood DL, Tsirka SE. Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway. J Neurochem. 2013;127(3):394-402. doi:10.1111/jnc.12404
  3. Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, Grivennikov IA, Andreeva LN, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med. 2001;131(4):315-7. doi:10.1023/a:1017979514274
  4. Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, et al. [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorg Khim. 2001;27(3):180-3. PMID: 11443939
  5. Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein Pept Lett. 2018;25(10):914-923. doi:10.2174/0929866525666180925144642
  6. Povarov IS, Kondratenko RV, Derevyagin VI, Myasoedov NF, Skrebitsky VG. Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons. Bull Exp Biol Med. 2017;162(5):640-642. doi:10.1007/s10517-017-3676-3
  7. Filatova E, Kasian A, Kolomin T, Rybalkina E, Alieva A, Andreeva L, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Front Pharmacol. 2017;8:89. doi:10.3389/fphar.2017.00089
  8. Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016;7:31. doi:10.3389/fphar.2016.00031
  9. Kolomin TA, Agapova TIu, Agniullin IaV, Shram SI, Shadrina MI, Slominskiĭ PA, et al. [Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank]. Zh Vyssh Nerv Deiat Im I P Pavlova. 2013;63(3):365-74. PMID: 24450168
  10. Kolomin T, Shadrina M, Andreeva L, Slominsky P, Limborska S, Myasoedov N. Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. Regul Pept. 2011;170(1-3):18-23. doi:10.1016/j.regpep.2011.05.001
  11. Vasil'eva EV, Kondrakhin EA, Salimov RM, Kovalev GI. [COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.]. Eksp Klin Farmakol. 2016;79(9):3-11. PMID: 29787664
  12. Kolik LG, Nadorova AV, Antipova TA, Kruglov SV, Kudrin VS, Durnev AD. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med. 2019;167(5):641-644. doi:10.1007/s10517-019-04588-9
  13. Leonidovna YA, Aleksandrovna SM, Aleksandrovna TA, Aleksandrovna BO, Fedorovich MN, Aleksandrovna AL. The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. Curr Rev Clin Exp Pharmacol. 2021;16(2):162-167. doi:10.2174/1574884715666200704152810
  14. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. doi:10.1007/s11095-009-0045-6

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.